Company Overview of ProFibrix, BV.
ProFibrix, BV. develops and markets products for hemostasis and regenerative medicine markets. It offers Fibrocaps, a dry powder topical fibrin sealant based on a mixture of fibrinogen and thrombin, which helps to stop bleeding during surgery and after trauma injury. The company offers its products based on human fibrinogen, a natural blood protein for blood clotting and tissue healing. ProFibrix, BV. was founded in 2004 and is based in Leiden, the Netherlands with a subsidiary and office in Seattle, Washington. It has a manufacturing site in the United Kingdom. As of August 5, 2013, ProFibrix, BV. operates as a subsidiary of The Medicines Company.
Leiden, 2333 CR
Founded in 2004
31 88 730 8301
31 88 730 8383
Key Executives for ProFibrix, BV.
Similar Private Companies By Industry
|ACS Biomarker B.V.||Europe|
|Aduro Biotech Europe||Europe|
|Agventure Exploitatie BV||Europe|
|Alloksys Life Sciences BV||Europe|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
|Bloomberg L.P.||United States|
Sponsored Financial Commentaries
To contact ProFibrix, BV., please visit www.profibrix.com. Company data is provided by Capital IQ. Please use this form to report any data issues.